Independent
Tenure on this board
4.2 yrs
Meeting calendar
MD · Annual meeting · Thursday, May 7, 2026
Pediatrix Medical Group Inc
9 nominees · 4 ballot items.
Election of nine directors; ratification of PricewaterhouseCoopers LLP as independent auditors for 2026; advisory (non-binding) vote to approve 2025 executive compensation; approval of Second Amended and Restated 2008 Incentive Compensation Plan increasing share reserve and making administrative changes.
Market cap
$2.1B
1Y TSR
+94.4%
Board grade
B-
Record date
Mar 9, 2026
Filing
DEF 14A
Meeting concluded · May 7, 2026
Follow how the vote landed and what changed on Pediatrix Medical Group Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot4
- 1
Election of Pediatrix’s Directors
ManagementBoard: FORElect nine nominees — Laura A. Linynsky; Thomas A. McEachin; Kurt D. Newman, M.D.; Mark S. Ordan; Michael A. Rucker; Guy P. Sansone; John M. Starcher, Jr.; Shirley A. Weis; and Sylvia J. Young — each for a term expiring at the next annual meeting or until a successor is elected.
- 2
Ratification of the Appointment of Independent Auditors
ManagementBoard: FORRatify PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the 2026 fiscal year.
- 3
Advisory Vote on Executive Compensation (Say-on-Pay
ManagementBoard: FORNon-binding advisory vote to approve the compensation paid to the named executive officers for the 2025 fiscal year, as disclosed in the Proxy Statement.
- 4
Approval of the Pediatrix Medical Group, Inc. Second Amended and Restated 2008 Incentive Compensation Plan
ManagementBoard: FORApprove amendment to increase the Plan share reserve by 8,000,000 shares to 42,975,000, extend the Plan term, eliminate legacy provisions, and make administrative changes to maintain ability to grant equity awards.
Director elections
Nominees on the ballot9
Independent
Tenure on this board
6.0 yrs
Also a director at
Federal Realty Investment Trust (FRT)
Independent
Tenure on this board
1.1 yrs
Not independent
Tenure on this board
6.0 yrs
Also a director at
Carlyle Group Inc (CG)
Independent
Tenure on this board
7.2 yrs
Independent
Tenure on this board
6.0 yrs
Also a director at
Cvs Health Corp (CVS)
Independent
Tenure on this board
6.0 yrs
Independent
Tenure on this board
6.0 yrs
Independent
Tenure on this board
3.2 yrs
Also a director at
Lincoln Educational Services Corp (LINC)
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 11.1% | 9,110,244 | $195M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 7.5% | 6,154,126 | $132M |
| 3 | AMERICAN CENTURY COMPANIES INC | 4.8% | 3,925,366 | $84M |
| 4 | VICTORY CAPITAL MANAGEMENT INC | 4.7% | 3,841,933 | $82M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 3,656,321 | $78M |
| 6 | DIMENSIONAL FUND ADVISORS LP | 4.4% | 3,649,679 | $78M |
| 7 | STATE STREET CORP | 4.1% | 3,378,500 | $72M |
| 8 | BlackRock, Inc. | 3.3% | 2,741,613 | $59M |
| 9 | FMR LLC | 2.8% | 2,264,779 | $48M |
| 10 | WASATCH ADVISORS LP | 2.5% | 2,050,524 | $44M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Pediatrix Medical Group Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.4B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.7B
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$1.7B
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Haemonetics CorpHAE
Annual meeting·Jul 24, 2026·$3.5B
Organon & CoOGN
Special meeting·Jul 23, 2026·$3.6B
Reference
Frequently asked questions
- When is the Pediatrix Medical Group Inc 2026 annual meeting?
- Pediatrix Medical Group Inc (MD) holds its 2026 annual shareholder meeting on Thursday, May 7, 2026.
- What is the record date for the Pediatrix Medical Group Inc 2026 meeting?
- The record date for the Pediatrix Medical Group Inc 2026 meeting is Monday, March 9, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Pediatrix Medical Group Inc's 2026 meeting?
- The board is presenting 9 director nominees at the Pediatrix Medical Group Inc 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Pediatrix Medical Group Inc 2026 meeting?
- Shareholders will vote on 4 proposals at the Pediatrix Medical Group Inc 2026 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.